John D. Couling - 01 Jun 2026 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
03 Jun 2026, 16:43:12 UTC
Prior SEC filing
06 May 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling

Key filing fact

John D. Couling filed Form 4 for Dolby Laboratories, Inc. (DLB) on 03 Jun 2026.

Key facts

  • This page summarizes John D. Couling's Form 4 filing for Dolby Laboratories, Inc. (DLB).
  • 4 reported transactions and 1 derivative row are listed below.
  • Accepted by SEC: 03 Jun 2026, 16:43.

Change

  • Previous filing in this sequence was filed on 06 May 2026.
  • Current net transaction value: -$426,420.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001894052 Primary reporting owner

Couling John D

Relationship
SVP, Entertainment
Address
C/O DOLBY LABORATORIES, INC., 1275 MARKET STREET, SAN FRANCISCO
Signature
/s/ Daniel Rodriguez as Attorney-in-Fact for John Couling
Signature date
03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

DLB transaction

Class A Common Stock

Options Exercise

Transaction value
Shares
+7,666
Change %
+6.5%
Price
$45.50*
Shares after
126,393
Date
01 Jun 2026
Ownership
Direct
Footnotes
F1, F2
DLB transaction

Class A Common Stock

Sale

Transaction value
$397,890
Shares
-7,158
Change %
-5.7%
Price
$55.59
Shares after
119,235
Date
01 Jun 2026
Ownership
Direct
Footnotes
F1, F3
DLB transaction

Class A Common Stock

Sale

Transaction value
$28,529
Shares
-508
Change %
-0.43%
Price
$56.16
Shares after
118,727
Date
01 Jun 2026
Ownership
Direct
Footnotes
F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

DLB transaction Derivative

Employee Stock Option (Right to Buy)

Options Exercise

Transaction value
Shares
-7,666
Change %
-20%
Price
$0.000000*
Shares after
30,668
Date
01 Jun 2026
Ownership
Direct
Underlying class
Class A Common Stock
Underlying amount
7,666
Exercise price
$45.50
Footnotes
F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Shares held following the reported transactions include 55,114 shares of Class A common stock underlying restricted stock units, which are subject to forfeiture until they vest.

Footnote F2

Shares include 374 shares acquired under the Issuer's Employee Stock Purchase Plan on May 15, 2026.

Footnote F3

The shares were sold in multiple transactions at prices ranging from $55.15 to $56.105 , inclusive. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. The shares were sold pursuant to a 10b5-1 trading plan adopted on February 3, 2026.

Footnote F4

This option was granted for a total of 46,000 shares of Class A Common Stock. The option exercised in this transation was fully vested and exercisable as of the transaction date.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .